{"entity":{"type":"insider","cik":"0001674232","url":"/insider/0001674232","json_url":"/insider/0001674232.json","name":"McDowell Caryn Gordon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":68,"n_filings":7,"first":"2017-08-10","last":"2022-06-08","span_basis":"filed_date"},"name_variants":[{"name":"McDowell Caryn Gordon","source":"filing","n_filings":7,"first_seen":"2017-08-10","last_seen":"2022-06-08"}],"transactions":[{"id":6105426,"accession":"0001209191-22-035014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-035014","line_url":"/filing/0001209191-22-035014#line-2","is_derivative":false,"issuer_cik":"0001662774","issuer_name":"Cortexyme, Inc.","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001662774","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (Chief Legal & Adm. Officer)","officer_title":"Chief Legal & Adm. Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":2.8632,"price_display":"2.86","price_state":"stated","total_value":30922.56,"total_display":"30,922.56","shares_owned_after":122500.0,"shares_owned_after_display":"122,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-06","filed_date":"2022-06-08","scope":"insider"},{"id":6571340,"accession":"0001061983-18-000007","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001061983-18-000007","line_url":"/filing/0001061983-18-000007#line-12","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":653.0,"shares_display":"653","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":5877.0,"total_display":"5,877.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":6571337,"accession":"0001061983-18-000007","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001061983-18-000007","line_url":"/filing/0001061983-18-000007#line-11","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":652.0,"shares_display":"652","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":5868.0,"total_display":"5,868.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":6571336,"accession":"0001061983-18-000007","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001061983-18-000007","line_url":"/filing/0001061983-18-000007#line-10","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":5625.0,"total_display":"5,625.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":6571333,"accession":"0001061983-18-000007","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001061983-18-000007","line_url":"/filing/0001061983-18-000007#line-9","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":5625.0,"total_display":"5,625.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":6571330,"accession":"0001061983-18-000007","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001061983-18-000007","line_url":"/filing/0001061983-18-000007#line-8","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77.0,"shares_display":"77","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":693.0,"total_display":"693.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":6571328,"accession":"0001061983-18-000007","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001061983-18-000007","line_url":"/filing/0001061983-18-000007#line-7","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77.0,"shares_display":"77","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":693.0,"total_display":"693.00","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":4220598,"accession":"0001061983-17-000065","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-17-000065","line_url":"/filing/0001061983-17-000065#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2460.0,"shares_display":"2,460","price_per_share":12.9,"price_display":"12.90","price_state":"stated","total_value":31734.0,"total_display":"31,734.00","shares_owned_after":15522.0,"shares_owned_after_display":"15,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider"},{"id":4220593,"accession":"0001061983-17-000065","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-17-000065","line_url":"/filing/0001061983-17-000065#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":23400.0,"total_display":"23,400.00","shares_owned_after":14375.0,"shares_owned_after_display":"14,375","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-06","scope":"insider"},{"id":4071511,"accession":"0001061983-17-000060","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-22","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":15.2,"price_display":"15.20","price_state":"stated","total_value":30400.0,"total_display":"30,400.00","shares_owned_after":22726.0,"shares_owned_after_display":"22,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071509,"accession":"0001061983-17-000060","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-21","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1598.0,"shares_display":"1,598","price_per_share":15.7,"price_display":"15.70","price_state":"stated","total_value":25088.6,"total_display":"25,088.60","shares_owned_after":16771.0,"shares_owned_after_display":"16,771","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071507,"accession":"0001061983-17-000060","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-20","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1106.0,"shares_display":"1,106","price_per_share":15.35,"price_display":"15.35","price_state":"stated","total_value":16977.1,"total_display":"16,977.10","shares_owned_after":24669.0,"shares_owned_after_display":"24,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071504,"accession":"0001061983-17-000060","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-19","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":15.7,"price_display":"15.70","price_state":"stated","total_value":17270.0,"total_display":"17,270.00","shares_owned_after":18869.0,"shares_owned_after_display":"18,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071501,"accession":"0001061983-17-000060","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-18","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":15.6,"price_display":"15.60","price_state":"stated","total_value":17160.0,"total_display":"17,160.00","shares_owned_after":21669.0,"shares_owned_after_display":"21,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071496,"accession":"0001061983-17-000060","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-17","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1094.0,"shares_display":"1,094","price_per_share":15.3,"price_display":"15.30","price_state":"stated","total_value":16738.2,"total_display":"16,738.20","shares_owned_after":25975.0,"shares_owned_after_display":"25,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071494,"accession":"0001061983-17-000060","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-16","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":15.675,"price_display":"15.68","price_state":"stated","total_value":12540.0,"total_display":"12,540.00","shares_owned_after":19969.0,"shares_owned_after_display":"19,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071490,"accession":"0001061983-17-000060","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-15","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":15.65,"price_display":"15.65","price_state":"stated","total_value":10955.0,"total_display":"10,955.00","shares_owned_after":20769.0,"shares_owned_after_display":"20,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071484,"accession":"0001061983-17-000060","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-14","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":15.55,"price_display":"15.55","price_state":"stated","total_value":10885.0,"total_display":"10,885.00","shares_owned_after":23169.0,"shares_owned_after_display":"23,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071479,"accession":"0001061983-17-000060","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-13","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":15.4,"price_display":"15.40","price_state":"stated","total_value":9240.0,"total_display":"9,240.00","shares_owned_after":24069.0,"shares_owned_after_display":"24,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071476,"accession":"0001061983-17-000060","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-12","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":15.25,"price_display":"15.25","price_state":"stated","total_value":7625.0,"total_display":"7,625.00","shares_owned_after":23733.0,"shares_owned_after_display":"23,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071472,"accession":"0001061983-17-000060","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-11","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":15.575,"price_display":"15.58","price_state":"stated","total_value":6230.0,"total_display":"6,230.00","shares_owned_after":22769.0,"shares_owned_after_display":"22,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071469,"accession":"0001061983-17-000060","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-10","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":383.0,"shares_display":"383","price_per_share":15.275,"price_display":"15.28","price_state":"stated","total_value":5850.325,"total_display":"5,850.32","shares_owned_after":27069.0,"shares_owned_after_display":"27,069","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071467,"accession":"0001061983-17-000060","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-9","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":15.95,"price_display":"15.95","price_state":"stated","total_value":3190.0,"total_display":"3,190.00","shares_owned_after":18369.0,"shares_owned_after_display":"18,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071463,"accession":"0001061983-17-000060","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-8","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":15.75,"price_display":"15.75","price_state":"stated","total_value":3150.0,"total_display":"3,150.00","shares_owned_after":18569.0,"shares_owned_after_display":"18,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071460,"accession":"0001061983-17-000060","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-7","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":15.625,"price_display":"15.62","price_state":"stated","total_value":3125.0,"total_display":"3,125.00","shares_owned_after":21469.0,"shares_owned_after_display":"21,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071455,"accession":"0001061983-17-000060","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-6","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":3100.0,"total_display":"3,100.00","shares_owned_after":23869.0,"shares_owned_after_display":"23,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071452,"accession":"0001061983-17-000060","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-5","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":15.325,"price_display":"15.32","price_state":"stated","total_value":3065.0,"total_display":"3,065.00","shares_owned_after":25775.0,"shares_owned_after_display":"25,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":4071447,"accession":"0001061983-17-000060","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001061983-17-000060","line_url":"/filing/0001061983-17-000060#line-4","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":15.725,"price_display":"15.72","price_state":"stated","total_value":1572.5,"total_display":"1,572.50","shares_owned_after":18769.0,"shares_owned_after_display":"18,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-06","filed_date":"2017-10-10","scope":"insider"},{"id":5013270,"accession":"0001061983-17-000057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001061983-17-000057","line_url":"/filing/0001061983-17-000057#line-1","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","shares_owned_after":18369.0,"shares_owned_after_display":"18,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301766,"accession":"0001061983-17-000056","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-30","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":898.0,"shares_display":"898","price_per_share":14.2,"price_display":"14.20","price_state":"stated","total_value":12751.6,"total_display":"12,751.60","shares_owned_after":27302.0,"shares_owned_after_display":"27,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301760,"accession":"0001061983-17-000056","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-29","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":724.0,"shares_display":"724","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":10751.4,"total_display":"10,751.40","shares_owned_after":20176.0,"shares_owned_after_display":"20,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301755,"accession":"0001061983-17-000056","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-28","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":707.0,"shares_display":"707","price_per_share":14.95,"price_display":"14.95","price_state":"stated","total_value":10569.65,"total_display":"10,569.65","shares_owned_after":18469.0,"shares_owned_after_display":"18,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301751,"accession":"0001061983-17-000056","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-27","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":14.6,"price_display":"14.60","price_state":"stated","total_value":10220.0,"total_display":"10,220.00","shares_owned_after":23600.0,"shares_owned_after_display":"23,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301748,"accession":"0001061983-17-000056","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-26","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.9,"price_display":"14.90","price_state":"stated","total_value":8940.0,"total_display":"8,940.00","shares_owned_after":19576.0,"shares_owned_after_display":"19,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301745,"accession":"0001061983-17-000056","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-25","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.75,"price_display":"14.75","price_state":"stated","total_value":8850.0,"total_display":"8,850.00","shares_owned_after":21800.0,"shares_owned_after_display":"21,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301741,"accession":"0001061983-17-000056","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-24","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":14.45,"price_display":"14.45","price_state":"stated","total_value":8670.0,"total_display":"8,670.00","shares_owned_after":25100.0,"shares_owned_after_display":"25,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301740,"accession":"0001061983-17-000056","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-23","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":14.7,"price_display":"14.70","price_state":"stated","total_value":7350.0,"total_display":"7,350.00","shares_owned_after":22600.0,"shares_owned_after_display":"22,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301734,"accession":"0001061983-17-000056","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-22","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":14.925,"price_display":"14.92","price_state":"stated","total_value":5970.0,"total_display":"5,970.00","shares_owned_after":19176.0,"shares_owned_after_display":"19,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301732,"accession":"0001061983-17-000056","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-21","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":14.8,"price_display":"14.80","price_state":"stated","total_value":5920.0,"total_display":"5,920.00","shares_owned_after":21000.0,"shares_owned_after_display":"21,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301727,"accession":"0001061983-17-000056","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-20","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":14.775,"price_display":"14.78","price_state":"stated","total_value":5910.0,"total_display":"5,910.00","shares_owned_after":21400.0,"shares_owned_after_display":"21,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301722,"accession":"0001061983-17-000056","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-19","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":14.4,"price_display":"14.40","price_state":"stated","total_value":5760.0,"total_display":"5,760.00","shares_owned_after":25700.0,"shares_owned_after_display":"25,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301719,"accession":"0001061983-17-000056","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-18","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":5700.0,"total_display":"5,700.00","shares_owned_after":26902.0,"shares_owned_after_display":"26,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301715,"accession":"0001061983-17-000056","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-17","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":302.0,"shares_display":"302","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":4318.6,"total_display":"4,318.60","shares_owned_after":26500.0,"shares_owned_after_display":"26,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301710,"accession":"0001061983-17-000056","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-16","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":14.625,"price_display":"14.62","price_state":"stated","total_value":4387.5,"total_display":"4,387.50","shares_owned_after":23300.0,"shares_owned_after_display":"23,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301706,"accession":"0001061983-17-000056","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-15","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.725,"price_display":"14.72","price_state":"stated","total_value":2945.0,"total_display":"2,945.00","shares_owned_after":22400.0,"shares_owned_after_display":"22,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301702,"accession":"0001061983-17-000056","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-14","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.65,"price_display":"14.65","price_state":"stated","total_value":2930.0,"total_display":"2,930.00","shares_owned_after":23100.0,"shares_owned_after_display":"23,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301698,"accession":"0001061983-17-000056","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-13","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.575,"price_display":"14.58","price_state":"stated","total_value":2915.0,"total_display":"2,915.00","shares_owned_after":24300.0,"shares_owned_after_display":"24,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301694,"accession":"0001061983-17-000056","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-12","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.525,"price_display":"14.52","price_state":"stated","total_value":2905.0,"total_display":"2,905.00","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301690,"accession":"0001061983-17-000056","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-11","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":2900.0,"total_display":"2,900.00","shares_owned_after":24700.0,"shares_owned_after_display":"24,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"},{"id":4301687,"accession":"0001061983-17-000056","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001061983-17-000056","line_url":"/filing/0001061983-17-000056#line-10","is_derivative":false,"issuer_cik":"0001061983","issuer_name":"CYTOKINETICS INC","issuer_ticker":"CYTK","issuer_name_source":null,"issuer_url":"/issuer/0001061983","owner_cik":"0001674232","owner_name":"McDowell Caryn Gordon","owner_url":"/insider/0001674232","role":"Officer (GC & Chief Compliance Officer)","officer_title":"GC & Chief Compliance Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":14.475,"price_display":"14.48","price_state":"stated","total_value":2895.0,"total_display":"2,895.00","shares_owned_after":24900.0,"shares_owned_after_display":"24,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-08","scope":"insider"}],"next_cursor":"2017-09-06|4301687","ledger_fault":false,"count":{"value":68,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":68,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":68},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001662774","name":"Cortexyme, Inc.","url":"/issuer/0001662774","role":"Officer (Chief Legal & Adm. Officer)","n_filings":1,"first_seen":"2022-06-08","last_seen":"2022-06-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001061983","name":"CYTOKINETICS INC","url":"/issuer/0001061983","role":"Officer (GC & Chief Compliance Officer)","n_filings":6,"first_seen":"2017-08-10","last_seen":"2018-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001674232","retrieved_at":"2026-08-21T16:37:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}